-HME Healthcare launches microbiome next-generation sequencing (NGS) service
– Formal agreement with Novogen, laying the foundation for competition with large domestic NGS companies through the company’s unique microbiome big data analysis capabilities
-HME Healthcare, a company developing artificial intelligence infectious disease diagnosis using NGS and discovering new drug candidates derived from microorganisms
‘HME Healthcare Co., Ltd. (CEO Park Tae-jin)’ announced on the 26th that it will provide microbiome next-generation sequencing (NGS) services in the medical, agricultural, livestock, fisheries, fermented foods, and environment fields.
HME Healthcare was able to use the latest NGS equipment through an official agreement with Novogen, the world’s largest NGS service company, in December last year. By adding our own customized microbiome (microbial genome) big data analysis capabilities, we have laid the foundation for competing with large NGS companies.
Based on microbiome big data, HME Healthcare is developing an artificial intelligence-based diagnosis of antibiotic-resistant bacteria and a platform for discovering natural antibiotic candidates from microorganisms derived from the deep sea floor and traditional fermented foods using multi-omics. Currently, joint research is being conducted with Wonju Severance Hospital, Korea Institute of Ocean Science and Technology, Chonnam National University, and the Ministry of Environment.
CEO Taejin Park said, “Currently, NGS services around the world are mainly based on genome analysis of hosts such as humans and animals, and the market has already reached saturation. However, the microbiome NGS analysis service market is just beginning.”
CEO Park continued, “In addition to NGS services, we are looking for investors who will lead the development of innovative solutions for host infection diagnosis and treatment through microbiome big data analysis.”
HME Healthcare is planning to establish an overseas subsidiary ‘HME Bioinfor Co., Ltd.’ in March this year for a bioinformatics center in Hong Kong.
Meanwhile, HME Healthcare received support for commercialization funds and mentoring from the Gyeonggi Creative Economy Innovation Center and the Agricultural Technology Commercialization Foundation, which are the organizations in charge of the 2020 Ministry of SMEs and Startups Preliminary Startup Package.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2021’ news